At Congruence, our purpose is to enhance the clinical and commercial impact of injectable drugs and vaccines that have unsolved, emerging and hard-to-address delivery needs.
The world of injectable drugs is continually evolving, growing and diversifying. These changes continually generate new, compelling drug delivery needs. However, many incumbent drug delivery device companies are not structured or focused in a way that allows them to identify and address these needs adequately. In short, delivery device development has often lagged advances in pharmaceutical science, meaning pharma and biotech companies have sometimes adopted suboptimal delivery solutions for critical therapies.
Our goal is to address this gap. We want to be the company that pharmas and biotechs turn to when they need a knowledgeable device partner that has proactively developed innovative, practical platform solutions. We also want to be responsive, agile and humble enough to continue to anticipate and innovate to address their evolving needs.